Clinical

The AJMC^® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care^® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

MRI head brain scan - DedMityay - stock.adobe.com

Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

By Pearl Steinzor

July 18th 2025

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

DLBCL | Image: Atlas of Haematological Cytology

Lack of CD20 Expression Worsens Outcomes for Bispecifics in R/R DLBCL

By Mary Caffrey

July 16th 2025

Myasthenia gravis diagnosis | Image Credit: syahrir-stock.adobe.com

Potential Link Found Between Obesity and Myasthenia Gravis Exacerbation

By Maggie L. Shaw

July 15th 2025

Rise in drug pricing | Image Credit: Alex Puhovoy - stock.adobe.com

Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

By Brooke McCormick

July 14th 2025

health care providers - Kirsten D:peopleimages.com.jpeg

Colorectal Cancer Shared Care Model Gains Support From Clinicians

By Pearl Steinzor

July 14th 2025

More News

Complexities in Diabetes Care in 2017

Complexities in Diabetes Care in 2017

Watch

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

Watch

Role of the Health Plan in Providing Support to Members With Diabetes

Role of the Health Plan in Providing Support to Members With Diabetes

Watch

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

Watch

An Increased Emphasis on Individual Risk Factors and Goals

An Increased Emphasis on Individual Risk Factors and Goals

Watch

Impact of Cost on Patients' Access to Treatment

Impact of Cost on Patients' Access to Treatment

Watch

How Drug Cost Influences Drug Selection

How Drug Cost Influences Drug Selection

Watch

Role of Early Intervention in Preventing Progression to T2D

Role of Early Intervention in Preventing Progression to T2D

Watch

Major Cost Drivers in T2D Management

Major Cost Drivers in T2D Management

Watch

Updates to Treatment Guidelines: Effects on Payers

Updates to Treatment Guidelines: Effects on Payers

Watch

Advantages of Medications that Treat Multiple Conditions

Advantages of Medications that Treat Multiple Conditions

Watch

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Watch

Considerations Regarding Statin Therapy

Considerations Regarding Statin Therapy

Watch

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Watch

Addressing the Effect of Polypharmacy on Medication Adherence

Addressing the Effect of Polypharmacy on Medication Adherence

Watch

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

Watch

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Watch

WellCare's Initiatives To Improve Care for Members With Diabetes

WellCare's Initiatives To Improve Care for Members With Diabetes

Watch

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Watch

The Influence of Lipid Guidelines on Real-World Practice Patterns

The Influence of Lipid Guidelines on Real-World Practice Patterns

Watch

Variables Involved When Adding Medications to Treat Diabetes

Variables Involved When Adding Medications to Treat Diabetes

Watch

How Does the Potential for Weight Gain Influence Choice of Therapies?

How Does the Potential for Weight Gain Influence Choice of Therapies?

Watch

Comparison of Guidelines From ADA and AACE

Comparison of Guidelines From ADA and AACE

Watch

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Watch

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

Surabhi Dangi-Garimella, PhD

Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.

Read More

"It Takes a Village" to Tackle the Diabetes Epidemic

"It Takes a Village" to Tackle the Diabetes Epidemic

Watch

What Is the Role of the Provider in Guiding People to Better Adherence?

What Is the Role of the Provider in Guiding People to Better Adherence?

Watch

Using Apps to Help Patients Manage Diabetes

Using Apps to Help Patients Manage Diabetes

Watch

How Can We Align Financing Incentives With Quality?

How Can We Align Financing Incentives With Quality?

Watch

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

Why Recent Clinical Trials Make This a "Very Exciting Time" in Diabetes Care

Watch

...

247 248 249 250 251 252 253 254 255

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions